GENE ONLINE|News &
Opinion
Blog

MSD
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
Merck Joins Forces with Daiichi Sankyo in $5.5 Billion Deal to Develop Cancer Drugs
2023-10-22
World Premiere of Documentary-style Film on the Battle Against Antibiotic Resistance
2023-09-06
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
FDA Blesses Merck’s Pneumococcal Vaccine for Pediatric Use
2022-06-23
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
As India Suffers Crisis, Merck Signs License Pact with 5 Indian Firms to Manufacture COVID-19 Drugs
2021-04-29
Keytruda Receives Two New Approvals in Japan
2020-08-30
Weekly Cover: Takeda Initiates Development of Potential COVID-19 Therapy TAK-888
2020-03-13
HIV
Weekly in Asia 2019|AUG-1
2019-08-17
Lynparza Meets Primary Endpoint in Phase III PROfound Trial
2019-08-16
LATEST
Pharmaceutical Giants Expand Research and Manufacturing Capabilities, Fueling 2024 Innovation and Growth
2024-03-01
An Interview with the Inventor of HPV Vaccine, Ian Frazer, Building a Firewall for Public Health
2024-02-29
Taiwan’s Drug Price Adjustments: Balancing Cost and Availability
2024-02-28
Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal
2024-02-27
Breakthrough Study Shows Anti-IgE Antibody Safeguards Children with Multiple Food Allergies
2024-02-27
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
EVENT
Scroll to Top